From: Characterisation of the vitreous proteome in proliferative diabetic retinopathy
Spot no.(a) | Protein name | Swiss-Prot Access | Biological process | Theoretical | Observed | Mascot Score(b) | Matched peptides | Ratio PDR: C(c) | ||
---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  | MW (Da) | PI | MW (kDa) | PI |  |  |  |
437 | Ig alpha-1 chain C | P01876 | immune response | 37630 | 6.08 | 63 | 6.4 | 281 | 9 | 5.45 |
441 | region | Â | Â | Â | Â | 63 | 6.0 | 366 | 13 | 4.29 |
443 | Â | Â | Â | Â | Â | 62 | 6.2 | 356 | 11 | 3.61 |
467 | Â | Â | Â | Â | Â | 63 | 5.8 | 364 | 10 | 3.39 |
500 | Â | Â | Â | Â | Â | 70 | 6.5 | 143 | 6 | -13.51 |
486 | Tubulin alpha-1B chain | P68363 | microtubule-based movement | 50119 | 4.94 | 67 | 6.9 | 100 | 10 | 2.36 |
520 | Keratin, type II | P35908 | keratinisation | 65393 | 8.07 | 60 | 6.6 | 344 | 11 | 2.01 |
740 | cytoskeletal 2 | Â | Â | Â | Â | 40 | 6.8 | 454 | 13 | -7.87 |
838 | epidermal | Â | Â | Â | Â | 33 | 7.6 | 102 | 6 | 3.11 |
844 | Â | Â | Â | Â | Â | 32 | 7.2 | 72 | 8 | 3.14 |
536 | Complement factor I | P05156 | immune response | 65677 | 7.72 | 61 | 6.7 | 116 | 8 | 2.29 |
537 | Beta-crystallin B1 | P53674 | visual perception | 28006 | 8.59 | 62 | 6.8 | 101 | 7 | 2.89 |
603 | Â | Â | Â | Â | Â | 60 | 5.2 | 120 | 7 | -2.55 |
645 | Â | Â | Â | Â | Â | 45 | 7.8 | 127 | 8 | -5.77 |
573 | Hemopexin | P02790 | transport | 51643 | 6.55 | 62 | 7.1 | 239 | 10 | 3.31 |
578 | Cathepsin D | P07339 | proteolysis | 44524 | 6.1 | 48 | 5.5 | 592 | 19 | -3.24 |
585 | Â | Â | Â | Â | Â | 49 | 5.6 | 361 | 18 | -2.85 |
580 | Pigment | P36955 | cell proliferation; | 46313 | 5.97 | 50 | 5.7 | 119 | 6 | -2.92 |
598 | epithelium-derived | Â | negative regulation of angiogenesis; | Â | Â | 47 | 5.8 | 194 | 7 | -2.96 |
599 | factor (PEDF) | Â | positive regulation of neurogenesis | Â | Â | 60 | 6.2 | 339 | 11 | -3.36 |
600 | Gamma-enolase | P09104 | glycolysis | 47239 | 4.91 | 60 | 5.2 | 625 | 19 | -25.63 |
639 | Zinc-alpha-2- | P25311 | fatty acid binding; | 33851 | 6.45 | 45 | 5.2 | 251 | 12 | 3.52 |
654 | glycoprotein | Â | ribonuclease activity | Â | Â | 43 | 5.4 | 150 | 13 | 2,99 |
667 | Â | Â | Â | Â | Â | 43 | 5.3 | 394 | 17 | 4.65 |
689 | Cytosolic acyl coenzyme A thioester hydrolase | O00154 | hydrolysis | 41769 | 8.85 | 40 | 7.6 | 134 | 7 | -7.16 |
725 | Ig heavy chain V-lll region BRO | P01766 | immune response | 13218 | 6.45 | 42 | 6.1 | 101 | 3 | -6.14 |
726 | N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | O94760 | arginine catabolic process; signal transduction | 31102 | 5.53 | 43 | 5.8 | 65 | 5 | -6.74 |
736 | Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) | P04406 | glycolysis | 36030 | 8.57 | 37 | 8.3 | 308 | 11 | -30.90 |
755 | Clusterin | P10909 | apoptosis; | 52461 | 5.89 | 38 | 4.8 | 521 | 19 | -3.43 |
763 | Â | Â | immune response | Â | Â | 40 | 4.5 | 314 | 12 | -2.56 |
766 | Â | Â | Â | Â | Â | 38 | 5.1 | 284 | 15 | -2.21 |
797 | Â | Â | Â | Â | Â | 34 | 5.5 | 114 | 2 | -3.92 |
800 | Â | Â | Â | Â | Â | 35 | 5.9 | 221 | 10 | -2.24 |
765 | Malate dehydrogenase | P40925 | tricarboxylic acid cycle | 36403 | 6.91 | 38 | 7.3 | 199 | 4 | -4.74 |
794 | Keratin, type I | P35527 | intermediate filament organisation | 62027 | 5.14 | 33 | 5.6 | 221 | 16 | -2.20 |
1078 | cytoskeletal 9 | Â | Â | Â | Â | 17 | 8.5 | 134 | 8 | -14.34 |
838 | Carbonic | P00918 | dehydratase activity; | 29228 | 6.87 | 32 | 8.2 | 223 | 8 | 3.11 |
854 | anhydrase 2 | Â | Â | Â | Â | 32 | 7.6 | 136 | 4 | 3.54 |
855 | Â | Â | zinc ion binding | Â | Â | 33 | 7.7 | 390 | 13 | 3.13 |
845 | Keratin, type II cytoskeletal 6A | P02538 | structural constituent of cytoskeleton | 60008 | 8.09 | 33 | 7.4 | 82 | 11 | 3.23 |
930 | Ig lambda-1 chain C regions | P01842 | immune response | 11230 | 6.92 | 30 | 5.6 | 95 | 4 | -2.61 |
942 | Prostaglandin-H2 | P41222 | biosynthesis; | 21015 | 7.66 | 28 | 4.9 | 91 | 4 | -2.53 |
990 | D-isomerase | Â | transport | Â | Â | 28 | 5.1 | 88 | 5 | -3.32 |
974 | Beta-crystallin S | P22914 | structural constituent of eye lens | 20993 | 6.44 | 28 | 6.8 | 147 | 4 | -27.42 |
978 | Â | Â | Â | Â | Â | 26 | 7.5 | 231 | 8 | -24.32 |
1019 | Â | Â | Â | Â | Â | 25 | 7.2 | 271 | 10 | -57.43 |
982 | Glutathione peroxidase 3 | P22352 | hydrogen peroxide catabolic process; oxidation/reduction | 25537 | 8.26 | 27 | 5.9 | 256 | 6 | -2.49 |
984 | Beta-crystallin B2 | P43320 | visual perception | 23365 | 6.50 | 27 | 8.0 | 113 | 5 | -15.21 |
1010 | Phosphatidylethanolamine-binding protein 1 | P30086 | protease inhibitor | 21044 | 7.01 | 28 | 8.3 | 437 | 12 | -39.30 |
1015 | Alpha-crystallin B chain | P02511 | anti-apoptosis; muscle contraction; intracellular transport; protein folding; protein homooligomerisation; response to heat | 20146 | 6.76 | 26 | 7.8 | 283 | 9 | -26.80 |
1049 | Beta-crystallin A4 | P53673 | visual perception | 22360 | 5.83 | 20 | 6.5 | 137 | 5 | -5.70 |
1021 | Beta-crystallin A3 | P05813 | visual perception | 25134 | 5.81 | 25 | 6.8 | 483 | 12 | -109.74 |
1022 | Â | Â | Â | Â | Â | 23 | 7.9 | 428 | 11 | -149.26 |
1023 | Â | Â | Â | Â | Â | 24 | 7.5 | 351 | 12 | -233.49 |
1024 | Gamma-crystallin C | P07315 | visual perception | 20865 | 6.88 | 23 | 7.8 | 395 | 12 | -147.83 |